Clinical trial designs to assess treatment effects on glomerular filtration rate decline-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical trial designs to assess treatment effects on glomerular filtration rate decline

Published:2024-07 Issue: Volume: Page:
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Heerspink Hiddo J.L.^ORCID,Little Dustin J.,Frison Lars,Gasparyan Samvel B.^ORCID,Wanner Christoph^ORCID,Jongs Niels,Postmus Douwe

Publisher

Elsevier BV

Reference14 articles.

1. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency;Levey;Am J Kidney Dis,2020

2. Design and baseline characteristics of the FIND-CKD Trial: efficacy of Finerenone on Kidney Disease Progression in People with Non-Diabetic CKD;Heerspink;J Am Soc Nephro,2023

3. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure;Inker;Nat Med,2023

4. Dapagliflozin in patients with chronic kidney disease;Heerspink;N Engl J Med,2020

5. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;Perkovic;N Engl J Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3